Newbridge Financial Services Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-77
| Closed | -$1.81K | – | 1049 |
|
|
2024
Q4 | $1.81K | Sell |
77
-14
| -15% | -$330 | ﹤0.01% | 978 |
|
|
2024
Q3 | $2.33K | Sell |
91
-444
| -83% | -$11.4K | ﹤0.01% | 551 |
|
|
2024
Q2 | $12.6K | Hold |
535
| – | – | ﹤0.01% | 663 |
|
|
2024
Q1 | $15.4K | Sell |
535
-114
| -18% | -$3.28K | 0.01% | 665 |
|
|
2023
Q4 | $21.3K | Buy |
649
+87
| +15% | +$2.86K | 0.01% | 582 |
|
|
2023
Q3 | $15.7K | Sell |
562
-251
| -31% | -$7K | 0.01% | 704 |
|
|
2023
Q2 | $27.7K | Sell |
813
-92
| -10% | -$3.14K | 0.01% | 597 |
|
|
2023
Q1 | $27.2K | Sell |
905
-457
| -34% | -$13.7K | 0.01% | 619 |
|
|
2022
Q4 | $38.5K | Hold |
1,362
| – | – | 0.02% | 527 |
|
|
2022
Q3 | $45K | Buy |
1,362
+215
| +19% | +$7.1K | 0.03% | 472 |
|
|
2022
Q2 | $36K | Buy |
1,147
+368
| +47% | +$11.6K | 0.02% | 480 |
|
|
2022
Q1 | $36K | Buy |
779
+120
| +18% | +$5.55K | 0.02% | 557 |
|
|
2021
Q4 | $40K | Sell |
659
-164
| -20% | -$9.95K | 0.02% | 523 |
|
|
2021
Q3 | $61K | Sell |
823
-96
| -10% | -$7.12K | 0.04% | 357 |
|
|
2021
Q2 | $85K | Buy |
919
+86
| +10% | +$7.95K | 0.05% | 313 |
|
|
2021
Q1 | $74K | Buy |
833
+732
| +725% | +$65K | 0.05% | 311 |
|
|
2020
Q4 | $9K | Buy |
+101
| New | +$9K | 0.01% | 748 |
|